Latest Breaking News On - Fertilisers mansukhl mandaviya - Page 1 : comparemela.com

Can Produce 2Bn Doses a Year of Most Covid Jabs : Pharma Giant Wockhardt to Centre Amid Shortage

The company’s process of ‘accessing’ technology to make some Covid-19 vaccines is already underway.

United kingdomJagran manchMansukhl mandaviyaAstrazeneca oxford universitySerum institute of indiaPharma giant wockhardt to centre amid shortageCan produceMost covid jabsPharma giant wockhardtCentre amidCentre amid shortageMumbai based wockhardtIndian expressNorth walesSwadeshi jagran manchFertilisers mansukhl mandaviya

Covid-19 | Govt overseeing the supply of treatment drugs, says Mandaviya

Mansukh Mandaviya The number of plants producing Remdesivir has been increased from 20 to 60, resulting in three times more availability in just 25 days, he said. The government is monitoring the supply of various essential drugs used in the treatment of COVID-19, Minister of State for Chemicals and Fertilisers Mansukh L Mandaviya said on Wednesday. In an official statement, the minister noted that all drugs used in the management of COVID-19 were now available in India after ramping up production and increasing the imports. The availability of these drugs is being monitored by implementing a three-pronged strategy of supply chain management, demand-side management and affordability, Mr. Mandaviya noted.

Mansukhl mandaviyaNational pharmaceutical pricing authorityCentral drugs standard control organisationFertilisers mansukhl mandaviyaEnoxaparin injectionMethylprednisolone injectionAmphoterecinb injectionCorona virusCovid 19Second waveதேசிய மருந்து ப்ரைஸிஂக் அதிகாரம்மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந்கொரோனா வைரஸ்இரண்டாவது அலை

Govt monitoring supply of various COVID treatment drugs: Mansukh Mandaviya

The government is monitoring the supply of various essential drugs used in the treatment of COVID-19, Minister of State for Chemicals and Fertilisers Mansukh L Mandaviya said on Wednesday. In an official statement, the minister noted that all drugs used in the management of COVID-19 were now available in India by ramping up production and increasing imports. The availability of these drugs is being monitored by implementing a three-pronged strategy of supply chain management, demand-side management and affordability, Mandaviya noted. The government is monitoring supply of various protocol drugs like Remdesivir, Enoxaparin, MethylPrednisolone, Dexamethasone, Tocilizumab and Ivermectin, he said. Besides, supply of other drugs like Favipiravir, Amphotericin and Apixamab is also being monitored, he added.

Mansukhl mandaviyaMansukh mandaviyaNational pharmaceutical pricing authorityCentral drugs standard control organisationImage sourceFertilisers mansukhl mandaviyaEnoxaparin injectionMethylprednisolone injectionAmphoterecinb injectionGovernment monitoringCovid 19 drugsMansukh mandaviyaCoronavirus pandemicOvid second waveCorona updatesCorona strain

25 new plants approved to enhance supply of Remdesivir: Mandaviya

25 new plants approved to enhance supply of Remdesivir: Mandaviya
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

Mansukhl mandaviyaNational pharmaceutical pricing authoritySyngene internationalFertilisers mansukhl mandaviyaJubilant genericsதேசிய மருந்து ப்ரைஸிஂக் அதிகாரம்மகிழ்ச்சி ஜெநெரிக்ஸ்

Customs duty waive off on Remdesivir will further augment domestic availability: Sadanand Gowda

3,029,815.0 The government s decision to waive off customs duty on antiviral drug Remdesivir would help in augmenting the supply of the medicine in the wake of soaring COVID-19 cases in the country, Chemicals and Fertilisers Minister Sadanand Gowda said on Wednesday. The government on Tuesday waived off all customs duty on imported Remdesivir injections and the drug s active pharmaceutical ingredients (API) in order to boost supplies. There is already a ban on the export of the Remdesivir injection from the country. Considering the immediate requirement on the recommendation of the Department of Pharmaceuticals, the Department of Revenue has reduced customs duty on #Remdesivir and its API/KSM. This step will further augment domestic availability of Remdesivir injection, Gowda said in a tweet.

Mansukhl mandaviyaSadanand gowdaDepartment of pharmaceuticalsNational pharmaceutical pricing authorityDepartment of revenueFertilisers minister sadanand gowdaFertilisers mansukhl mandaviyaRemdesivir vaccineCovid 19 casesCadila healthcareCorona virusUnion health ministryசாதானண்த் கவுடாதுறை ஆஃப் மருந்துகள்தேசிய மருந்து ப்ரைஸிஂக் அதிகாரம்துறை ஆஃப் வருவாய்